For citations:
Mangazeeva E.D., Studenikina A.A., Michailova E.S., Morozov D.V., Ryzhikova S.L., Druzhinina Yu.G., Proskura A.V., Bogachuk A.P., Lipkin V.M., Autenshlyus A.I. Сytokine production by the bioptates of invasive non- specific breast carcinoma as a criterion for the use of acetylamide form of synthetic HLDF-6 peptide for differentiation therapy of breast cancer. Medical Immunology (Russia). 2025;27(4):739-748. (In Russ.) https://doi.org/10.15789/1563-0625-CPB-3147
Email this article 